Shire and AbbVie still negotiating on break fee
Shire, an FTSE-100, pharmaceuticals company and listed Chicago, Illinois-based, rival AbbVie are still negotiating over a break fee with regards to Abbvie’s GBP 31bn (EUR 39.18bn) takeover bid, Financial Times reported.
The newspaper cited people close to the matter for the claim, which appeared in a longer report about the prospects of the deal being announced today, 18 July.
AbbVie is poised to announce a deal as early as this morning, the item said. However, people close to the talks cautioned that there is still a chance that the deal could collapse. The people added that an agreement is at hand following talks regarding terms.
Shire this week indicated that it was prepared to recommend AbbVie’s revised offer of GBP 53.20.
Shire and AbbVie refused to comment, the article said.
Source Financial Times